- Clinical Trials
- April 2024
- 200 Pages
Global
From €2383EUR$2,500USD£2,031GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1192EUR$1,250USD£1,016GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1192EUR$1,250USD£1,016GBP
- Report
- January 2022
- 200 Pages
Global
From €7150EUR$7,500USD£6,094GBP
- Report
- January 2022
- 60 Pages
Global
From €3766EUR$3,950USD£3,210GBP
- Report
- July 2023
- 92 Pages
Global
From €3500EUR$3,933USD£3,088GBP
- Report
- January 2021
- 143 Pages
China, Global
From €3000EUR$3,371USD£2,647GBP
- Report
- January 2021
- 140 Pages
China, Global
From €3000EUR$3,371USD£2,647GBP
- Report
- November 2022
- 61 Pages
Global
From €1907EUR$2,000USD£1,625GBP
- Report
- May 2022
- 41 Pages
Global
From €2383EUR$2,500USD£2,031GBP
- Report
- May 2022
- 37 Pages
Global
From €2383EUR$2,500USD£2,031GBP
- Drug Pipelines
- June 2020
- 53 Pages
Global
From €1907EUR$2,000USD£1,625GBP
- Report
- June 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,153GBP
- Report
- June 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,153GBP
- Report
- June 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,153GBP
- Report
- June 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,153GBP
- Report
- June 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,153GBP
- Report
- June 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,153GBP
- Report
- June 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,153GBP
- Report
- June 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,153GBP
Ornithine is a drug used to treat liver and kidney disorders. It is a derivative of the amino acid arginine and is used to reduce ammonia levels in the body. It is also used to treat urea cycle disorders, a group of genetic disorders that affect the body's ability to break down proteins. Ornithine is available in both oral and injectable forms. It is often used in combination with other drugs to treat liver and kidney disorders.
Ornithine is a popular drug in the market for liver and kidney disorders. It is used to reduce ammonia levels in the body and to treat urea cycle disorders. It is available in both oral and injectable forms and is often used in combination with other drugs.
Some companies in the Ornithine market include Merck, Pfizer, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more